The somatostatin analog 188Re-P2045 inhibits the growth of AR42J pancreatic tumor xenografts.

Saved in:
Bibliographic Details
Title: The somatostatin analog 188Re-P2045 inhibits the growth of AR42J pancreatic tumor xenografts.
Authors: Nelson CA; Translational Medicine Consulting, Westford, Massachusetts Department of Research and Development, Andarix Pharmaceuticals, Watertown, Massachusetts; and pharmacologyconsultants@gmail.com., Azure MT; Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama., Adams CT; Department of Research and Development, Andarix Pharmaceuticals, Watertown, Massachusetts; and., Zinn KR; Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2014 Dec; Vol. 55 (12), pp. 2020-5. Date of Electronic Publication: 2014 Oct 30.
Publication Type: Journal Article
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1535-5667
DOI:10.2967/jnumed.114.140780